Transvestite Advocating Puberty Blockers Joins WHO, Igniting Fierce Global Debate on Child Health Policy


The World Health Organization (WHO) is drawing sharp criticism for convening a task force charged with crafting guidelines on trans and gender-diverse health, featuring members whose views are causing a global stir.

Unprecedented Guidance Amidst Global Concern

In a move that’s rattling the pillars of health policy, the WHO has brought together a group to shape the future of trans health care. This panel includes a French-Canadian law professor, Florence Ashley, who is igniting debate with radical stances on gender and identity.

A Questionable Coalition

Ashley, self-identified as a “transfeminine activist, academic, and slut,” joins lobbyists notorious for advocating the removal of age limits on sex changes, drawing skepticism about the task force’s legitimacy. Ashley’s academic work posits, “Unbounded social transition and ready access to puberty blockers ought to be treated as the default option,” a perspective that has inflamed critics who see it as an extreme approach to youth gender dysphoria.

Activism Meets Academia

With Ashley’s appointment, the WHO has signaled a clear direction, sparking concerns from various quarters including Reem Alsalem, the U.N. special rapporteur on violence against women and girls. Alsalem condemns the task force’s “one-sided,” pro-medicalization bias, and a lack of diverse opinions that could challenge the activist-driven narrative.

The Clash of Ideologies

The task force’s composition, including figures from the World Professional Association for Transgender Health, suggests an alignment with groups pushing for controversial changes in trans health policies. Critics argue this could lead to a disregard for cautious medical practices, particularly for youth, and the protection of female-only spaces.

A Call for Rethinking the Approach

With the Clinical Advisory Network on Sex and Gender questioning the WHO’s stance on medical and surgical interventions for gender-affirming care, the controversy reaches a boiling point. “There are no robust randomized-controlled trials supporting gender-affirming medical and surgical interventions,” the group warns, suggesting that the WHO’s guidelines may be at odds with a cautious and evidence-based approach.


Please enter your comment!
Please enter your name here

Share post:




More like this

Dr. Phil Blasts Medical Industry’s Controversial Transgender Ideology on Kids with Joe Rogan

In a riveting discussion on "The Joe Rogan Experience,"...

Shocking Revelation: New Research Suggests Trump Was the True Victor of the 2020 Election

OPINION In a groundbreaking analysis that challenges the status quo,...

Star Wars No More: Gina Carano Strikes Back at Disney with Elon Musk in Her Corner

A Hero's Challenge In a defiant crusade for justice, Gina...